Delivery Order SPE2DB25D7068-SPE2DB25FTXZM
- Not listed
- The Defense Logistics Agency awarded a $13,446.66 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is issued under...
- The Defense Logistics Agency awarded a $16,986.52 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract includes no set-aside designation and was competitively awarded through open procurement channels. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,054.64 in Boostrix TDAP vaccine syringes (0.5ML) on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded contract, which carries no set-aside designation, represents a firm fixed price delivery order and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order falls under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) on August 11, 2025, with a ceiling value of $22,083.83. This firm fixed-price contract, with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with the DLA. The contract is unclassified as a set-aside and will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a $39,915.00 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Boostrix TDAP vaccine syringes (0.5mL). This firm fixed price delivery order, with an ultimate completion date of July 21, 2025, represents performance at the contractor's Conshohocken, Pennsylvania facility. The award was not designated as a set-aside contract and was competitively awarded to the prime contractor. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in syringe form (0.5mL) with a ceiling value of $1,064.40. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Boostrix TDAP vaccine in 0.5ML syringes, with a ceiling value of $7,592.10. This is a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,594.20 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ML syringes. This non-competitive delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a small-value transaction under a firm fixed-price arrangement. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. This firm fixed-price contract, valued at $1,064.40, represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 through December 2026. The delivery order was completed by September 8, 2025,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. This competitively awarded, non-set-aside contract carries a ceiling value of $4,470.50 and is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains operations as...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTXZMDelivery Order
The Defense Logistics Agency awarded a $1,064.40 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This is a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and the product will be performed and delivered from the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a child contract under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply vaccines, medications, and medical commodities to military healthcare systems and other government agencies, including the Defense Health Agency and U.S. Coast Guard. The current delivery order for TDAP vaccine reflects the company's ongoing role as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/15/25 |